Abstract
Alcohol consumption is generally well tolerated by the liver but in some individuals it results in persistent inflammation and liver disease. The mechanisms that regulate alcohol-induced liver inflammation are poorly understood. The transcription factor FOXO3 has previously been shown to be involved in suppressing alcohol-induced liver injury. In this study we demonstrate that in response to alcohol, approximately 10% of mouse hepatic macrophages undergo FOXO3-dependent apoptosis. By 3 days of alcohol exposure total hepatic macrophage numbers declined by 30% but these were restored to normal after 10 days of continued exposure. Whole body or myeloid specific Foxo3-/- mice failed to show this apoptotic response. After 10 days of alcohol exposure, Foxo3−/− mice had an increased basal inflammatory phenotype and an increase in the proportion of pro-inflammatory CD11b+, Ly6C+ infiltrating macrophages (IMs) infiltrating. This led to marked sensitivity to LPS with a 5-fold ALT elevation and liver injury after LPS challenge in Foxo3−/− but not WT mice. Restoring the early macrophage apoptosis burst with a pulse of intravenous GdCl3 at day 2 had no effect on the day 10 phenotype of WT mice but it corrected the hyper-inflammatory phenotype in Foxo3−/− mice. In conclusion, FOXO3-dependent hepatic macrophage apoptosis in response to ethanol serves to promote differentiation of infiltrating macrophages thus limiting the magnitude of the inflammatory response to ethanol.
Introduction
Alcoholic liver disease (ALD) is a leading cause of liver-related morbidity and mortality1,2. The pathogenesis of ALD is complex but it involves an ethanol-induced release of bacterial products from the intestine and a subsequent intrahepatic inflammatory cascade that interacts with a liver already altered by other effects of ethanol exposure3. This can progress to produce cirrhosis and/or liver failure4. ALD occurs only in a minority of heavy drinkers5 with the severe inflammatory manifestation of ALD, acute alcoholic hepatitis (AH), occurring even less frequently6. These observations suggest that the normal liver possesses protective mechanisms that minimize the inflammatory response and generally allow it to tolerate ethanol with minimal consequences. ALD and AH appear to occur upon failure of these protective mechanisms.
Hepatic macrophages are critical to the initiation and maintenance of the inflammatory state induced by alcohol7. They are a heterogeneous population consisting of Kupffer cells, yolk sac derived resident macrophages that have a largely anti-inflammatory and tissue surveillance phenotype, and infiltrating monocyte-derived macrophages (IMs) that carry out diverse pro- and anti-inflammatory functions8. Several investigators have previously observed the transient loss of hepatic resident macrophages in mice shortly after exposure of mice to ethanol9–11. During continued ethanol consumption, total hepatic macrophage numbers recover but there is a change of hepatic macrophage populations consisting of a disappearance of Kupffer cells, arrival of pro-inflammatory IMs and subsequent differentiation of these IMs to a more anti-inflammatory tissue repair phenotype12. The mechanisms underlying this anti-inflammatory shift of the macrophage population remain elusive but multiple studies have shown that it can be triggered by the presence of apoptotic bodies8, 13–15.
We have previously demonstrated that the transcription factor FOXO3 protects the liver from ethanol-induced inflammation in mice16. We further demonstrated that either ethanol or LPS causes phosphorylation of FOXO3 at S-574 which induces apoptosis in monocytes and macrophages17. In the current study we sought to determine whether FOXO3 orchestrates a macrophage apoptosis response to ethanol in vivo, and whether this apoptosis plays a role in modulating the hepatic inflammatory phenotype by inducing macrophage phenotype changes. The results show that ethanol feeding of mice results in FOXO3-dependent hepatic macrophage apoptosis. In the absence of FOXO3, this apoptosis process fails to occur and the liver subsequently adopts a more pro-inflammatory macrophage phenotype. Restoring a transient pulse of macrophage apoptosis the day after ethanol exposure significantly attenuated liver inflammation 10 days later in the ethanol-fed Foxo3−/− mice making them similar to WT mice. These results suggest that FOXO3 serves to limit ethanol-induced inflammation by inducing hepatic macrophage apoptosis with the apoptotic macrophages acting as a signal that subsequently promotes anti-inflammatory differentiation of intrahepatic macrophages.
Results
Acute ethanol gavage induces FOXO3-dependent Kupffer cell apoptosis
Ethanol administration to mice has been reported to induce hepatic macrophage apoptosis9 and transiently decrease macrophage number10, 11 and we have previously demonstrated that LPS induces FOXO3-dependent cell death in the THP-1 monocyte cell line17. We thus tested whether ethanol induced liver macrophage apoptosis was FOXO3-dependent. WT or Foxo3−/− mice were gavaged with ethanol (5 g/kg) and sacrificed 9 h later. This acute gavage protocol did not change serum alanine aminotransferase (ALT) activity (Fig. 1a) but, similar to previous reports11, it reduced the mRNA level of the hepatic macrophage maker F4/80 in WT mice. This effect was absent in Foxo3−/− mice (Fig. 1b). Immunohistochemical (IHC) staining confirmed that acute ethanol gavage significantly reduced F4/80 positive cells in WT mice (p < 0.05) but not Foxo3−/− mice (Fig. 1c). Ethanol gavage elevated the infiltrating macrophage marker CD11b18 but had no effect on a dendritic cell marker CD12319 in both WT and Foxo3−/− mice (Fig. 1b). There was a marked increase of TUNEL positive cells in WT (p < 0.01) but not Foxo3−/−mice after acute gavage (Fig. 1d). Co-staining with myeloid cell markers indicated that TUNEL+ cells were predominantly F4/80+ and there was no colocalization with either brightly staining CD11b+cells (infiltrating macrophages) or Ly6G+cells (neutrophils). There were few detectable CD11b+ cells in the liver by 9 h, suggesting that Kupffer cells were the main population responsible for the macrophage decrease after acute gavage. Approximately 10% of the F4/80+ cells underwent apoptosis in WT mice (Fig. 1e).
Myeloid cell FOXO3 is critical for ethanol induced macrophage apoptosis
We next determined whether voluntary ethanol feeding with a Lieber-DeCarli diet also induces macrophage apoptosis. In WT mice we observed approximately 9 and 7% of F4/80+ macrophages undergoing apoptosis after 3 and 11 days of ethanol, respectively (Fig. 2a, c). At 3 days there was an approximately 30% decrease of total F4/80+ cells in the liver (Fig. 2b). In Foxo3−/− mice, in contrast, there was significantly less macrophage apoptosis at both time points (Fig. 2a, b, c). By day 11, the total number of F4/80 positive cells in the liver had returned to baseline in both genotypes (Fig. 2d).
In order to examine whether myeloid FOXO3 itself is critical for ethanol induced macrophage apoptosis, we fed alcohol to mFoxo3−/− mice and matched littermate controls (Foxo3fl/fl) with the same diet for 10 days. As seen previously, approximately 8% of macrophages in WT mice were TUNEL positive, but similar to the situation in whole body Foxo3−/− mice, this was reduced to 2.8% in the mFoxo3−/− mice (Fig. 2e, P < 0.01). Macrophage apoptosis did not influence the total number of F4/80 positive cells 10 days after ethanol (Fig. 2f). This data suggests that myeloid FOXO3 is essential for ethanol induced macrophage apoptosis yet in spite of this early apoptosis phase, the total liver macrophage number is able to recover by day 11 of alcohol exposure.
Loss of FOXO3 exacerbates the pro-inflammatory macrophage phenotype in response to ethanol
To address the consequences of macrophage apoptosis, we fed mice with an ethanol containing Lieber-DeCarli diet for 10 days and examined the liver phenotype. Not surprisingly, this relatively brief exposure to ethanol did not produce liver injury in either genotype (Fig. 3a) and ethanol equally induced lipid accumulation (Fig. 3b). However, Foxo3−/− mice displayed a more pro-inflammatory liver phenotype as evidenced by greater mRNA expression of cytokines associated with pro-inflammatory macrophages such as TNF-α, IL-6, and MCP-1, and decreased expression of the anti-inflammatory Th2 cytokine IL-420 (Fig. 3c). 10 days after alcohol exposure, Foxo3−/− mice had increased liver mRNA expression of the classical macrophage marker iNOS21 and decreased alternative macrophage markers arginase 1 (Arg1) and resistin-like molecule alpha 1 (Retnla/Fizz-1)21 (Fig. 3d). Similar to whole body Foxo3−/− mice, mFoxo3−/− mice also displayed higher mRNA expression of IL-6, IL-1β and iNOS (Fig. 3e) and less expression of IL-4, Arg1 and another alternative macrophage marker, Ym-121. Serum levels of TNF-α, IL-6, and MCP-1 were significantly elevated in mFoxo3−/− mice (Fig. 3f). Taken together, these data demonstrate increased pro-inflammatory phenotype in the ethanol-fed Foxo3−/− and mFoxo3−/− mice.
The increased inflammatory phenotype in Foxo3−/− mice sensitizes the liver to LPS-induced injury
We next determined whether the ethanol-induced phenotype changes in Foxo3−/− mice altered inflammatory responses to LPS, a major pathogenic factor in ALD3. Mice were fed ethanol for 10 days and then administered a single intraperitoneal dose of LPS (10 µg, 0.5 mg/kg). In the absence of ethanol, LPS had no effect on serum ALT, inflammation, or macrophage or neutrophil infiltration in WT mice or Foxo3−/− mice (Figs. 4a, b, c). After 10 days of ethanol, however, LPS caused a more than 5-fold increase in serum ALT in Foxo3−/− mice (Fig. 4a, p < 0.01) but had no effect on WT mice. Livers from ethanol-fed Foxo3−/− mice treated with LPS had large areas of focal inflammation with ballooned, hyper-eosinophilic hepatocytes, hemorrhage, necrosis and macrophage and neutrophil infiltration (Figs. 4b, c). In pair-fed mice, LPS induced increases in TNF-α, IL-6, IL-1β and MCP-1 and these changes were nearly identical in WT and Foxo3−/− mice (Fig. 4d). Ethanol feeding by itself increased TNFα and IL-1β similarly to the effect of LPS but ethanol did not increase IL-6 or MCP-1. These baseline effects of ethanol in WT and Foxo3−/− mice were very similar. However, when ethanol feeding was combined with LPS administration, WT and Foxo3−/− mice behaved quite differently with 2–5 fold greater serum cytokine elevations in the Foxo3−/− mice (Fig. 4d). Findings of elevated serum IL-1β suggested inflammasome activation in ethanol/LPS treated Foxo3−/− mice. In the absence of LPS treatment, NLRP3, cleaved caspase-1 and cleaved IL-1β were similar between WT and Foxo3−/− mice and were not affected by ethanol feeding. LPS treatment of WT mice increased NLRP3 expression without a major change in cleaved caspase-1 or cleaved IL-1β. In ethanol-fed Foxo3−/− mice, however, LPS treatment resulted in a greater increase in NLRP3 and significantly increased pro-IL-1β, cleaved-caspase-1 and cleaved IL-1β (Fig. 4e). These data demonstrate enhanced LPS-induced inflammasome activation in ethanol-fed Foxo3−/− mice.
IMs are responsible for pro-inflammatory phenotype in ethanol-fed Foxo3−/− mice
We next assessed which cells were responsible for the inflammatory phenotype in Foxo3−/− mice. At the end of 11 days of alcohol feeding there were no differences in hepatic F4/80, CD11b, and CD123 mRNA levels between WT and Foxo3−/− mice (Fig. 5a). However, Ly6C, a marker for pro-inflammatory IMs22 was dramatically increased in Foxo3−/− mice (Fig. 5a, p < 0.001). Immunohistochemical staining showed significantly increased Ly6C+ cells in Foxo3−/− mice (Fig. 5b, p < 0.01). Co-staining indicated that the Ly6C+ cells were IMs as they primarily co-stained with CD11b (Figs 5c, S1A) but not with the T cell marker CD4 (Supplementary Fig. S1B). Similar to Foxo3−/− mice, mFoxo3−/− mice also developed a pro-inflammatory phenotype (Figs. 3e, f) with significantly higher Ly6C+ cells in the liver compared with control mice after 10 days of ethanol (Fig. 5c, P < 0.05).
We next isolated total CD11b+ cells from the liver and measured basal and LPS-induced cytokine production. We found that cells from Foxo3−/− mice had significantly higher basal mRNA expression of TNF-α, IL-6, and iNOS (Fig. 5d). In response to LPS, cells from Foxo3−/− mice produced significantly more TNF-α, IL-6, and MCP-1 (Fig. 5e). These observations indicate that after 11 days of alcohol exposure, hepatic macrophages from Foxo3−/− mice have an enhanced inflammatory phenotype with more Ly6C+cells, greater pro-inflammatory cytokine production and increased response to LPS.
Apoptosis is critical for promoting anti-inflammatory macrophage differentiation
Apoptotic cells are known to interact with phosphatidylserine receptors on macrophages where they synergize with IL4 and other Th2 cytokines to promote differentiation towards an anti-inflammatory tissue repair phenotype8, 13–15. We reasoned that the absence of an early apoptosis burst in Foxo3−/− mice might contribute to the failure of IMs to become more anti-inflammatory over time and thus account for the excess presence of Ly6C+ cells. To determine if the loss of macrophage apoptosis explains the persistence of a pro-inflammatory macrophage phenotype we assessed whether a pulse of macrophage apoptosis by a single injection of GdCl323–25 could correct the phenotype of Foxo3−/− mice. We first demonstrated that GdCl3 was able to induce macrophage apoptosis independent of the expression of FOXO3 (Supplementary Fig. S2A). Mice were then injected 1 day after ethanol exposure and cell death and inflammatory phenotype was evaluated 2 and 9 days post injection (dpi) (Fig. 6a). By 2 dpi there was a burst of TUNEL positivity of sinusoidal cells and a decrease of liver F4/80 mRNA that was similar in magnitude to that induced by alcohol in WT mice (Supplementary Fig. S2B, compare to Fig. 1b), but by 9 dpi, hepatic macrophage populations had recovered and excess TUNEL-positive sinusoidal cells were no longer detectible (Figs. 6b, c, S2B). In WT mice, GdCl3 had no effect on hepatic mRNA expression of cytokines or inflammatory or anti-inflammatory macrophage markers (Fig. 6d). However, in Foxo3−/− mice, the GdCl3 pulse dramatically decreased the inflammatory phenotype at 9 dpi, reducing Ly6C and pro-inflammatory markers, increasing anti-inflammatory markers and essentially correcting the abnormalities seen in the Foxo3−/− mice (Fig. 6d). We also observed a corresponding decrease in serum cytokine levels (Fig. 6e) suggesting that restoring an early apoptosis burst was able to partially correct the pro-inflammatory phenotype of alcohol-fed Foxo3−/− mice.
Discussion
Ethanol consumption has the potential to produce significant liver inflammation and injury through its effects on gut permeability, hepatocyte oxidative stress, and innate immune activation3. Nonetheless, most individuals who drink heavily do not develop liver disease, suggesting the existence intrinsic hepato-protection mechanisms. Findings from our lab previously demonstrated that FOXO3 serves as a protective factor for ethanol-induced liver injury16 and in response to ethanol, FOXO3 is phosphorylated at S-574 converting it into a factor that causes apoptosis in macrophages17. In this study we examined the connection between macrophage apoptosis and the control of liver inflammation. We confirmed that, as observed previously9, about 10% of resident hepatic macrophages undergo apoptosis in response to alcohol but total macrophage number is quickly restored. In Foxo3−/− mice, this initial burst of macrophage apoptosis is absent and 10 days later the hepatic macrophage pool has an abnormally pro-inflammatory phenotype. This creates the potential for liver injury in response to an LPS challenge such as might occur as a result of alcohol-induced changes in gut barrier function. Restoring a pulse of macrophage apoptosis, in this case with a single IV injection of GdCl3, was able to prevent the development of the pro-inflammatory phenotype in Foxo3−/− mice.
The process by which the hepatic macrophage pool adapts over the course of alcohol exposure and the importance of this adaptation to controlling liver inflammation is only partially understood. Previous studies have shown that ethanol consumption by mice initially results in the appearance of pro-inflammatory Ly6Chi, monocyte-derived macrophages in the liver. Over time these cells differentiate into Ly6Clow, anti-inflammatory macrophages limiting ethanol-induced inflammation12. Cytokines such as IL4 and IL13 as well as apoptotic bodies have long been understood to promote this anti-inflammatory macrophage differentiation but recently it has emerged that the presence of signaling cascades initiated by apoptotic body/receptor interactions are essential in order for IL-4 and IL-13 to promote alternative, anti-inflammatory macrophage differentiation15. Macrophage cell death similarly induces anti-inflammatory macrophage differentiation after bacterial infection8, 26. Our studies support this concept and demonstrate that apoptosis of resident macrophages supplies a signal that promotes the differentiation of IMs.
Although Foxo3−/− mice have an increased inflammatory phenotype after 10-day alcohol exposure, they do not develop spontaneous liver injury. Liver injury occurred only when we challenged these mice with a low, ordinarily nontoxic dose of LPS. Gut-derived LPS plays a critical role in initiating the inflammatory response of the liver to ethanol exposure27–30 but is not of itself sufficient to produce liver injury. Injury may only occur when elevated LPS translocation interacts with a state of enhanced hepatic LPS sensitivity.
Our finding that ethanol induces apoptosis of about 10% of intrahepatic macrophages confirms a number of previous findings. Macrophage apoptosis has been observed under many circumstances including during response to bacterial infection31, and it can be directly produced by exposure to LPS32, particularly under conditions in which NF-κB activation is inhibited33. Ethanol-induced intrahepatic macrophage apoptosis has been most definitively shown by Cohen et al.9 who did simultaneous TUNEL assays and immuno-histochemical stains which showed that ethanol induces Kupffer cell apoptosis associated with an early spike of pro-inflammatory cytokine expression10. Here we identified that FOXO3 is crucial for this ethanol induced macrophage apoptosis. This is consistent with our previous demonstration that ethanol-induced, JNK-dependent phosphorylation of FOXO3 at S-574 triggers monocyte and macrophage apoptosis by induction of pro-apoptotic genes and suppression of Bcl-217.
There have been suggestions that hepatocyte apoptosis occurs in alcoholic hepatitis and that apoptotic bodies derived from hepatocytes may be responsible for macrophage differentiation12. It is plausible that FOXO3 might also be responsible for a low level of hepatocyte apoptosis in response to ethanol due to its induction of Bim34 and/or PUMA35, but in these studies of early liver effects from a relatively low-dose alcohol exposure we did not detect appreciable hepatocyte apoptosis after ethanol and both whole body and myeloid specific Foxo3−/− mice developed a similar inflammatory phenotype. Nonetheless, we considered the possibility that loss of an apoptotic pathway in Foxo3−/− hepatocytes might potentiate non-apoptotic hepatocyte death which would contribute liver injury36 by converting the more benign apoptosis process into the more pro-inflammatory process of necroptosis. We measured key components of necroptosis, RIPK1, RIPK3 and caspase 8 cleavage in our mice after 3 weeks of ethanol (Supplementary Fig. S3). There were equal increases of RIPK3 expression and caspase 8 activation in both WT and Foxo3−/− mice (Supplementary Fig. S3A–B) thus suggesting that the phenotype of the Foxo3−/− mice is not due to increased ethanol-induced hepatocyte necroptosis.
Further evidence supporting a role of FOXO3-dependent myeloid cell apoptosis in adaptation of the liver to alcohol comes from recent studies from our lab showing that alterations of myeloid cell FOXO3 function are present in alcoholic hepatitis patients. Monocytes from patients with alcoholic hepatitis fail to undergo normal FOXO3 phosphorylation and apoptosis in response to LPS37. In this case, the defect was attributed to a change in FOXO3 acetylation state. This defect, if present in intrahepatic macrophages as well, could contribute to the unusual sensitivity to ethanol in alcoholic hepatitis patients. Overall, our results are consistent with the following working hypothesis. Under normal conditions, exposure of the liver to ethanol causes JNK-dependent S-574 phosphorylation of FOXO3 and subsequent apoptosis in about 10% of Kupffer cells. These apoptotic bodies interact with pro-inflammatory Ly6C+ infiltrating macrophages that enter the liver in response to alcohol and synergize with IL-4 to induce a delayed differentiation of the IMs to a more tissue repair and less inflammatory phenotype. This allows the liver to adapt to alcohol by downregulating the innate immune response.
In conclusion, this study has demonstrated that an early burst of FOXO3-dependent macrophage apoptosis plays a role in the evolution of the inflammatory environment of the liver after ethanol exposure. This effect tends to limit the intrahepatic inflammatory response and may contribute to hepatic ethanol tolerance. In the absence of this FOXO3-dependent mechanism, the liver displays hypersensitivity to LPS-induced injury. Defects in the FOXO3 apoptosis pathway have been observed in circulating monocytes from patients with alcoholic hepatitis37 and this supports the importance of this pathway in hepato-protection from ethanol.
Materials and methods
Animals and treatments
Foxo3−/− mice were provided by Dr. Kana Miyamoto (Keio University, Tokyo) and were generated as described38. Heterozygotes were bred together, obtaining both knockout and wild-type (WT) littermates. To generate myeloid specific FOXO3 knockout mice (mFoxo3−/−), Foxo3fl/fl mice with a floxed FOXO3 allele exon 2 (Jackson Labs, Bar Harbor, ME) were backcrossed into the C57BL/6 background for six generations. They were then bred with mice expressing the Cre recombinase under the control of lysozyme 2 gene (Lyz2) promoter/enhancer elements (B6.129P2-Lyz2tm1(cre)Ifo/J, hereafter LysM cre, Jackson Labs). They were used for ethanol feeding experiments at 3 to 6 months of age. All mice were housed in a temperature-controlled, specific pathogen-free environment with 12-h light-dark cycles and fed regular mouse chow and water ad libitum. All animal handling procedures were approved by the Institutional Animal Care and Use Committees at the University of Kansas Medical Center (Kansas City, KS).
We used mice of different genders for specific experiments to be consistent with previous reports39, 40. For acute ethanol feeding, female mice were gavaged with ethanol (5 g/kg body weight) in the morning and sacrificed 9 h later39. For voluntary ethanol feeding, female and male mice were initially fed the control Lieber-DeCarli diet (BioServ, Flemington, NJ) ad libitum for 5 days to acclimatize them to a liquid diet. Then mice were allowed free access to the ethanol Lieber-DeCarli diet containing 5% (vol/vol) ethanol for 10 days, and control-fed groups were pair-fed with the isocaloric control diet. For LPS injection, male mice were fed with liquid diet ethanol feeding described above40. At the end of study, all mice received a single intraperitoneal injection of 10 μg LPS (E. coli, Serotype O55:B5 S-form, Enzo Life Science, Farmingdale, NY) and sacrificed 6 h later. Liver tissue and venous blood were obtained. Serum was stored at −80 °C. Liver samples were fixed in formalin for histological examination or frozen in liquid nitrogen and stored at −80 °C. Total liver lysates were prepared using RIPA buffer [1% NP40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl (lauryl) sulfate].
Immunohistochemistry
Liver tissue sections (5 μm thick) were prepared from paraffin-embedded samples as previously described16. Immunohistochemistry (IHC) was performed by deparaffinization and rehydration, followed by antigen retrieval by heating in a pressure cooker (121 °C) for 5 min. Peroxidase activity was blocked by incubation in 3% hydrogen peroxide for 10 min. Sections were rinsed three times in TBS-T (20 mM Tris, pH 7.6. 150 mM NaCl. 0.1% Tween 20) and incubated in 5% normal goat serum in TBS-T at room temperature for 1 h. After removal of blocking solution, slides were placed into a humidified chamber and incubated with primary antibodies in blocking buffer (3% normal goat serum in PBS) and incubated over night at 4 °C. After washing, slides were covered with SignalStain Boost IHC Detection Reagent (Cell Signaling Technologies, Boston, MA) for 30 min at room temperature. After washing two times with TBS-T, the Substrate-Chromgen Solution (VECTOR NovaRED, Substrate Kit, Vector Laboratories, Burlingame, CA) was applied, slides were incubated 5–10 min and counterstained with Hemtoxylin. For immunofluorescent staining of Ly6C and CD11b, paraffin sections were permeabilized with 0.2% Triton-100 for 20 min and were blocked with protein block (DAKO, Santa Clara, CA) for 15 min followed by overnight incubation with the primary CD11b and Ly6C antibodies (1:200). After washing with PBS (3 times, 5 min each), sections were incubated with Alexa Fluor 488-conjugated goat anti-rabbit IgG or Alexa Fluor 594-conjugated donkey anti-rat IgG (1: 5000; Molecular Probes, Waltham, MA) for 1 h in the dark at room temperature.
TUNEL staining
Cell death was detected in situ in mouse liver paraffin-embedded sections by enzymatic labeling of DNA strand breaks with a TUNEL assay kit (In Situ Cell Death Detection Kit, Roche, Indianapolis, IN) according to the manufacturer’s instructions, followed by counterstaining with ethyl-[4-[[4-[ethyl-[(3-sulfophenyl) methyl] amino] phenyl]-(4-hydroxy-2-sulfophenyl) methylidene]-1-cyclohexa-2, 5-dienylidene]-[(3-sulfophenyl) methyl] azanium), (Fast Green FCF, Acros Organics, NJ,). Quantification of all TUNEL staining was performed by examining at least five randomly selected fields in each liver section by two investigators who were blinded to sample identity.
For double staining of TUNEL and myeloid cell markers, frozen liver section were mounted on glass slides, fixed with paraformaldehyde and washed in PBS. Sections were then blocked with protein block (DAKO, Santa Clara, CA) for 15 min followed by overnight incubation with the primary F4/80, CD11b or Ly6G antibodies (1:200). After washing with PBS, sections were incubated with Alexa Fluor 594-conjugated goat anti-rabbit IgG or donkey anti-rat IgG (1: 5000; Molecular Probes, Waltham, MA) for 1 h in the dark at room temperature. All sections were additionally stained for apoptotic cells using the in situ Cell Death Detection Kit (Fluorescein, Roche) according to the manufacturer’s instructions. Images were acquired using a Nikon Eclipse Ti microscope (Nikon Americas Inc., Melville, NY).
Isolation of liver infiltrating macrophages
Infiltrating macrophages were isolated using a multi-step collagenase procedure41 and then subjected to centrifugation on a Percoll (Sigma-Aldrich, St. Louis, MO) gradient. In brief, the liver was perfused with calcium-free solution and then digested with a collagenase (Sigma-Aldrich) perfusion. Dispersed cells were released from the isolated liver, and hepatocytes were collected by 50×g centrifugation. Non-parenchymal cells were fractionated by Percoll gradient at 1350 g for 10 min and infiltrating macrophages were purified by using CD11b magnetic beads (Miltenyi Biotec, Auburn, CA). For in vitro co-culture with apoptotic macrophages, CD11b+ hepatic macrophages were isolated from mice that had been either pair-fed or ethanol-fed for 2 days. Apoptosis was induced by incubating mouse primary peritoneal macrophages17 with Etopside (200 µM, Sigma-Aldrich) at 37 °C for 5 h. This preparation yielded > 90% TUNEL-positive apoptotic cells by 5 h and after 24 h there were no detectable mRNA could be isolated from these cells. The hepatic CD11b+ cells (5 × 105) were then co-cultured with 5 × 105 apoptotic macrophages for 24 h and mRNA was isolated and used for expression analysis.
Real-time PCR
RNA was extracted and purified from mouse liver or isolated cells using the RNeasy Mini Kit (Qiagen, Valencia, CA). cDNA was generated with the RNA reverse transcription kit (Applied Biosystems, Warrington, UK). Quantitative RT-PCR was performed in a CFX96 real-time system (Bio-Rad, Hercules, CA) using specific sense and antisense primers in 25 μl reaction volumes containing 12.5 μl SYBR Green PCR master mix (Applied Biosystems), 10.5 μl of 1 μmol/l primer stock and 2 μl cDNA. Primer sequences are presented in Supplementary Table 1.
Induction of macrophage apoptosis in vivo
Mice received a single intravenous (i.v) injections of GdCl3 (25 mg/kg, Sigma-Aldrich) or saline (0.9% NaCl, Baxter Healthcare Co, Deerfield, IL) via tail vein 1 day after ethanol exposure. Macrophage apoptosis was assessed at 2 days post injection.
Antibodies
Anti-F4/80 (SP115) antibody was purchased from Novus (Littleton, CA). Anti-Ly6G (ab25377), anti-CD11b (ab133357) and anti-Ly6C (ab15627) were purchased from Abcam (Cambridge, MA).
ALT assay and ELISA measurement
Serum ALTs were measured by commercial kit (TECO Diagnostics, Anaheim, CA). TNF-α, IL-6 levels were measured with ELISA Ready-SET-Go! kits (eBioscience, San Diego, CA) in serum according to the manufacturer’s protocol. IL-1β and MCP-1 were measured with DouSet ELISA kit from R&D Systems (Minneapolis, MN) according to the manufacturer’s protocol.
Statistical analysis
Data were presented as mean ± standard error of the mean (SEM). Statistical significance between two groups was calculated by 2-tailed unpaired Student’s t-test. Unless otherwise stated, a P-value of <0.05 was considered significant.
Acknowledgements
We thank Dr. Tiangang Li (The University of Kansas Medical Center) for advice and Dr. Kana Miyamoto (Keio University) for providing Foxo3−/− mice. This study was supported by grant AA012863 from the National Institute on Alcoholism and Alcohol Abuse, support from the Smith Intellectual and Developmental Disabilities Research Center (NIH U54 HD 090216), and a fellowship grant from the Biomedical Research Training Program of the University of Kansas Medical Center to ZL.
Supplementary information
Competing interests
The authors declare that they have no competing interests.
Footnotes
Edited by N. Barlev
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information accompanies this paper at 10.1038/s41420-017-0020-7.
References
- 1.Tilg H, Day CP. Management strategies in alcoholic liver disease. Nat. Clin. Pract. Gastroenterol. Hepatol. 2007;4:24–34. doi: 10.1038/ncpgasthep0683. [DOI] [PubMed] [Google Scholar]
- 2.Adachi M, Brenner DA. Clinical syndromes of alcoholic liver disease. Dig. Dis. 2005;23:255–263. doi: 10.1159/000090173. [DOI] [PubMed] [Google Scholar]
- 3.Szabo G. Gut-liver axis in alcoholic liver disease. Gastroenterology. 2015;148:30–36. doi: 10.1053/j.gastro.2014.10.042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Hritz I, et al. Bone marrow-derived immune cells mediate sensitization to liver injury in a myeloid differentiation factor 88-dependent fashion. Hepatology. 2008;48:1342–1347. doi: 10.1002/hep.22557. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Day CP, Bassendine MF. Genetic predisposition to alcoholic liver disease. Gut. 1992;33:1444–1447. doi: 10.1136/gut.33.11.1444. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Bruha R, Dvorak K, Petrtyl J. Alcoholic liver disease. World J. Hepatol. 2012;4:81–90. doi: 10.4254/wjh.v4.i3.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Beier JI, McClain CJ. Mechanisms and cell signaling in alcoholic liver disease. Biol. Chem. 2010;391:1249–1264. doi: 10.1515/bc.2010.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Sica A, Invernizzi P, Mantovani A. Macrophage plasticity and polarization in liver homeostasis and pathology. Hepatology. 2014;59:2034–2042. doi: 10.1002/hep.26754. [DOI] [PubMed] [Google Scholar]
- 9.Cohen JI, Roychowdhury S, McMullen MR, Stavitsky AB, Nagy LE. Complement and alcoholic liver disease: role of C1q in the pathogenesis of ethanol-induced liver injury in mice. Gastroenterology. 2010;139:664–674. doi: 10.1053/j.gastro.2010.04.041. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Roychowdhury S, et al. An early complement-dependent and TLR-4-independent phase in the pathogenesis of ethanol-induced liver injury in mice. Hepatology. 2009;49:1326–1334. doi: 10.1002/hep.22776. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Bertola A, Park O, Gao B. Chronic plus binge ethanol feeding synergistically induces neutrophil infiltration and liver injury in mice: a critical role for E-selectin. Hepatology. 2013;58:1814–1823. doi: 10.1002/hep.26419. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Wang M, et al. Chronic alcohol ingestion modulates hepatic macrophage populations and functions in mice. J. Leukoc. Biol. 2014;96:657–665. doi: 10.1189/jlb.6A0114-004RR. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Weigert A, Brune B. Nitric oxide, apoptosis and macrophage polarization during tumor progression. Nitric. Oxide. 2008;19:95–102. doi: 10.1016/j.niox.2008.04.021. [DOI] [PubMed] [Google Scholar]
- 14.Weis N, Weigert A, von Knethen A, Brune B. Heme oxygenase-1 contributes to an alternative macrophage activation profile induced by apoptotic cell supernatants. Mol. Biol. Cell. 2009;20:1280–1288. doi: 10.1091/mbc.E08-10-1005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Bosurgi L, et al. Macrophage function in tissue repair and remodeling requires IL-4 or IL-13 with apoptotic cells. Science. 2017;356:1072–1076. doi: 10.1126/science.aai8132. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Tumurbaatar B. et al. Hepatitis C and alcohol exacerbate liver injury by suppression of FOXO3. Am. J. Pathol.183, 1803–1814 (2013). [DOI] [PMC free article] [PubMed]
- 17.Li Z, et al. Serine 574 phosphorylation alters transcriptional programming of FOXO3 by selectively enhancing apoptotic gene expression. Cell. Death. Differ. 2016;23:583–595. doi: 10.1038/cdd.2015.125. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Tacke F, Zimmermann HW. Macrophage heterogeneity in liver injury and fibrosis. J. Hepatol. 2014;60:1090–1096. doi: 10.1016/j.jhep.2013.12.025. [DOI] [PubMed] [Google Scholar]
- 19.Hiasa Y, et al. Dendritic cell subtypes in autoimmune liver diseases; decreased expression of HLA DR and CD123 on type 2 dendritic cells. Hepatol. Res.: Off. J. Jpn. Soc. Hepatol. 2002;22:241–249. doi: 10.1016/S1386-6346(01)00149-8. [DOI] [PubMed] [Google Scholar]
- 20.Van Dyken SJ, Locksley RM. Interleukin-4 and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease. Annu. Rev. Immunol. 2013;31:317–343. doi: 10.1146/annurev-immunol-032712-095906. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Lawrence T, Natoli G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat. Rev. Immunol. 2011;11:750–761. doi: 10.1038/nri3088. [DOI] [PubMed] [Google Scholar]
- 22.Yang J, Zhang L, Yu C, Yang XF, Wang H. Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases. Biomark. Res. 2014;2:1. doi: 10.1186/2050-7771-2-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Mizgerd JP, Molina RM, Stearns RC, Brain JD, Warner AE. Gadolinium induces macrophage apoptosis. J. Leukoc. Biol. 1996;59:189–195. doi: 10.1002/jlb.59.2.189. [DOI] [PubMed] [Google Scholar]
- 24.Hardonk MJ, Dijkhuis FW, Hulstaert CE, Koudstaal J. Heterogeneity of rat liver and spleen macrophages in gadolinium chloride-induced elimination and repopulation. J. Leukoc. Biol. 1992;52:296–302. doi: 10.1002/jlb.52.3.296. [DOI] [PubMed] [Google Scholar]
- 25.Miron VE, et al. M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat. Neurosci. 2013;16:1211–1218. doi: 10.1038/nn.3469. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Gleissner CA. Macrophage Phenotype Modulation by CXCL4 in Atherosclerosis. Front. Physiol. 2012;3:1. doi: 10.3389/fphys.2012.00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Enomoto N, et al. Development of a new, simple rat model of early alcohol-induced liver injury based on sensitization of Kupffer cells. Hepatology. 1999;29:1680–1689. doi: 10.1002/hep.510290633. [DOI] [PubMed] [Google Scholar]
- 28.Bautista AP. Acute ethanol binge followed by withdrawal regulates production of reactive oxygen species and cytokine-induced neutrophil chemoattractant and liver injury during reperfusion after hepatic ischemia. Antioxid. Redox Signal. 2002;4:721–731. doi: 10.1089/152308602760598864. [DOI] [PubMed] [Google Scholar]
- 29.McClain CJ, Barve S, Barve S, Deaciuc I, Hill DB. Tumor necrosis factor and alcoholic liver disease. Alcohol. Clin. Exp. Res. 1998;22(5 Suppl):248S–252SS. doi: 10.1111/j.1530-0277.1998.tb04011.x. [DOI] [PubMed] [Google Scholar]
- 30.Uesugi T, et al. Delivery of IkappaB superrepressor gene with adenovirus reduces early alcohol-induced liver injury in rats. Hepatology. 2001;34:1149–1157. doi: 10.1053/jhep.2001.29400. [DOI] [PubMed] [Google Scholar]
- 31.Bleriot C, et al. Liver-resident macrophage necroptosis orchestrates type 1 microbicidal inflammation and type-2-mediated tissue repair during bacterial infection. Immunity. 2015;42:145–158. doi: 10.1016/j.immuni.2014.12.020. [DOI] [PubMed] [Google Scholar]
- 32.Mitchell RA, et al. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibitingp53: regulatory role in the innate immune response. Proc. Natl. Acad. Sci. USA. 2002;99:345–350. doi: 10.1073/pnas.012511599. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Pagliari LJ, Perlman H, Liu H, Pope RM. Macrophages require constitutive NF-kappaB activation to maintain A1 expression and mitochondrial homeostasis. Mol. Cell. Biol. 2000;20:8855–8865. doi: 10.1128/MCB.20.23.8855-8865.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Tao GZ, et al. Wnt/beta-catenin signaling protects mouse liver against oxidative stress-induced apoptosis through the inhibition of forkhead transcription factor FoxO3. J. Biol. Chem. 2013;288:17214–17224. doi: 10.1074/jbc.M112.445965. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.You H, et al. FOXO3a-dependent regulation of Puma in response to cytokine/growth factor withdrawal. J. Exp. Med. 2006;203:1657–1663. doi: 10.1084/jem.20060353. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Ni HM, et al. Caspase Inhibition Prevents Tumor Necrosis Factor-alpha-Induced Apoptosis and Promotes Necrotic Cell Death in Mouse Hepatocytes in Vivo and in Vitro. Am. J. Pathol. 2016;186:2623–2636. doi: 10.1016/j.ajpath.2016.06.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Li Z, Bridges B, Olson J, Weinman SA. The interaction between acetylation and serine-574 phosphorylation regulates the apoptotic function of FOXO3. Oncogene. 2017;36:1887–1898. doi: 10.1038/onc.2016.359. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Miyamoto K, et al. Foxo3a is essential for maintenance of the hematopoietic stem cell pool. Cell. Stem. Cell. 2007;1:101–112. doi: 10.1016/j.stem.2007.02.001. [DOI] [PubMed] [Google Scholar]
- 39.Bertola A, Mathews S, Ki SH, Wang H, Gao B. Mouse model of chronic and binge ethanol feeding (the NIAAA model) Nat. Protoc. 2013;8:627–637. doi: 10.1038/nprot.2013.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Koteish A, Yang S, Lin H, Huang X, Diehl AM. Chronic ethanol exposure potentiates lipopolysaccharide liver injury despite inhibiting Jun N-terminal kinase and caspase 3 activation. J. Biol. Chem. 2002;277:13037–13044. doi: 10.1074/jbc.M101632200. [DOI] [PubMed] [Google Scholar]
- 41.Xie Y, et al. Mechanisms of acetaminophen-induced cell death in primary human hepatocytes. Toxicol. Appl. Pharmacol. 2014;279:266–274. doi: 10.1016/j.taap.2014.05.010. [DOI] [PMC free article] [PubMed] [Google Scholar]